Bharat Biotech, IVI launch Chikungunya Vaccine Phase 2/3 trial in Costa Rica August 25, 2021 Auto Bot News 0 CEPI first partnered with IVI and Bharat Biotech in June 2020, providing up to USD 14.1 million for vaccine manufacturing and clinical development of the BBV87 vaccine candidate.